| Literature DB >> 31816017 |
Chelsea E Canan1, Tabor E Flickinger1, Marika Waselewski1, Alexa Tabackman2, Logan Baker3, Samuel Eger3, Ava Lena D Waldman1, Karen Ingersoll4, Rebecca Dillingham1.
Abstract
PositiveLinks (PL) is a multi-feature smartphone-based platform to improve engagement-in-care and viral suppression (VS) among clinic patients living with HIV. Features include medication reminders, mood/stress check-ins, a community board, and secure provider messaging. Our goal was to examine how PL users interact with the app and determine whether usage patterns correlate with clinical outcomes. Patients (N = 83) at a university-based Ryan White clinic enrolled in PL from June 2016 to March 2017 and were followed for up to 12 months. A subset (N = 49) completed interviews after 3 weeks of enrollment to explore their experiences with and opinions of PL. We differentiated PL members based on 6-month usage of app features using latent class analysis. We explored characteristics associated with class membership, compared reported needs and preferences by class, and examined association between class and VS. The sample of 83 PL members fell into four classes. "Maximizers" used all app features frequently (27%); "Check-in Users" tended to interact only with daily queries (22%); "Moderate All-Feature Users" used all features occasionally (33%); and "As-Needed Communicators" interacted with the app minimally (19%). VS improved or remained high among all classes after 6 months. VS remained high at 12 months among Maximizers (baseline and 12-month VS: 100%, 94%), Check-in Users (82%, 100%), and Moderate All-Feature Users (73%, 94%) but not among As-Needed Communicators (69%, 60%). This mixed-methods study identified four classes based on PL usage patterns that were distinct in characteristics and clinical outcomes. Identifying and characterizing mHealth user classes offers opportunities to tailor interventions appropriately based on patient needs and preferences as well as to provide targeted alternative support to achieve clinical goals.Entities:
Keywords: Latent class analysis; Mobile health; PLWH; Viral suppression
Mesh:
Year: 2021 PMID: 31816017 PMCID: PMC7877298 DOI: 10.1093/tbm/ibz180
Source DB: PubMed Journal: Transl Behav Med ISSN: 1613-9860 Impact factor: 3.046
Characteristics by class
| Maximizers | Check-in Users | Moderate All-Feature Users | As-Needed Communicators | Total |
| |
|---|---|---|---|---|---|---|
| Demographic characteristics | ||||||
| Age, median (IQR) | 48 (41–54) | 50 (35–54) | 46 (32–49) | 37 (24–49) | 46 (33–53) | .052 |
| Sex, | ||||||
| Male | 13 (59.1) | 12 (66.7) | 14 (51.8) | 12 (75.0) | 51 (61.5) | .511 |
| Female | 8 (36.4) | 6 (33.3) | 12 (44.4) | 3 (18.8) | 29 (34.9) | |
| Other/Unknowna | 1 (4.5) | 0 (0) | 1 (3.7) | 1 (6.3) | 3 (3.6) | |
| Race, | ||||||
| Black | 8 (36.4) | 15 (83.3) | 13 (48.2) | 6 (37.5) | 42 (50.6) | .038 |
| White | 7 (31.8) | 0 (0) | 10 (37.0) | 4 (25.0) | 21 (25.3) | |
| Hispanic | 1 (4.6) | 1 (5.6) | 0 (0) | 2 (12.5) | 4 (4.8) | |
| Multiple races | 4 (18.2) | 1 (5.6) | 2 (7.4) | 2 (12.5) | 9 (10.8) | |
| Other/Unknown | 2 (9.1) | 0 (0) | 2 (7.4) | 2 (12.5) | (8.4) | |
| Education, | ||||||
| Less than HS | 4 (19.1) | 3 (16.7) | 6 (23.0) | 4 (25.0) | 17 (21.3) | .488 |
| HS or equivalent | 6 (28.6) | 9 (50.0) | 10 (38.5) | 8 (50.0) | 33 (41.3) | |
| Some college | 8 (38.1) | 6 (33.3) | 5 (19.2) | 4 (25.0) | 23 (28.7) | |
| College degree | 3 (14.3) | 0 (0) | 3 (11.5) | 0 (0) | 7 (8.8) | |
| |
|
|
|
|
| |
| Income, | ||||||
| <100% FPL | 14 (63.6) | 14 (77.7) | 19 (73.1) | 12 (85.7) | 59 (73.8) | .365 |
| ≥100% FPL | 8 (36.4) | 4 (22.2) | 7 (26.9) | 2 (14.3) | 21 (26.3) | |
| |
|
|
|
|
| |
| Insurance, | ||||||
| Private | 12 (54.6) | 11 (61.1) | 17 (62.9) | 6 (37.5) | 46 (55.4) | .714 |
| Public | 8 (36.4) | 6 (33.3) | 7 (25.9) | 7 (43.8) | 28 (33.7) | |
| None | 2 (9.1) | 1 (5.6) | 3 (11.1) | 3 (18.8) | 9 (10.8) | |
| Distrust of medical systemb, median (IQR) | 22 (20–25) | 20 (20–26) | 22 (20–26) | 24 (22–28) | 22 (20–26) | .341 |
| |
|
|
|
|
| |
| Baseline clinical characteristics | ||||||
| CD4, median (IQR) | 779 (426–986) | 620 (228–931) | 576 (355–853) | 479 (195–828) | 603 (353–885) | .393 |
| |
|
|
|
|
| |
| Viral suppression, | 21 (100.0) | 14 (82.4) | 19 (73.1) | 9 (69.2) | 63 (81.8) | .026 |
| |
|
|
|
|
| |
| Engaged in carec, | 16 (72.7) | 13 (72.1) | 21 (77.8) | 13 (81.3) | 63 (75.9) | .927 |
| Taking ART, | 21 (100.0) | 17 (94.4) | 22 (88.0) | 15 (93.4) | 75 (93.8) | .468 |
| |
|
|
|
|
| |
| App usage | ||||||
| Medication response | ||||||
| ≥90% | 22 (100.0) | 18 (100.0) | 3 (11.1) | 0 (0) | 43 (51.8) | <.001 |
| 48%–90% | 0 (0) | 0 (0) | 24 (88.9) | 0 (0) | 24 (28.9) | |
| <48% | 0 (0) | 0 (0) | 0 | 16 (100.0) | 16 (19.3) | |
| Mood response | ||||||
| ≥90% | 22 (100.0) | 17 (94.4) | 1 (3.7) | 0 (0) | 40 (48.2) | <.001 |
| 48%–90% | 0 (0) | 1 (5.6) | 26 (96.3) | 0 (0) | 27 (32.5) | |
| <48% | 0 (0) | 0 (0) | 0 (0) | 16 (100.0) | 16 (19.3) | |
| Stress response | ||||||
| ≥90% | 22 (100.0) | 18 (100.0) | 0 (0) | 0 (0) | 40 (48.2) | <.001 |
| 48%–90% | 0 (0) | 0 (0) | 27 (100.0) | 1 (6.3) | 28 (33.7) | |
| <48% | 0 (0) | 0 (0) | 0 (0) | 15 (93.8) | 15 (18.1) | |
| Quiz response | ||||||
| ≥90% | 12 (54.6) | 16 (88.9) | 1 (3.7) | 0 (0) | 29 (34.9) | <.001 |
| 48%–90% | 8 (36.4) | 2 (11.1) | 21 (77.8) | 0 (0) | 31 (37.4) | |
| <48% | 2 (9.1) | 0 (0) | 5 (18.5) | 16 (100.0) | 23 (27.7) | |
| Community board posts | ||||||
| ≥1 | 21 (95.5) | 6 (33.3) | 12 (44.4) | 6 (37.5) | 45 (54.2) | <.001 |
| 0 | 1 (4.6) | 12 (66.7) | 15 (56.6) | 10 (62.5) | 38 (45.8) | |
| Messages sent | ||||||
| ≥7 | 17 (77.3) | 0 (0) | 7 (25.9) | 5 (31.3) | 29 (34.9) | <.001 |
| 1–6 | 0 (0) | 15 (83.3) | 14 (51.9) | 5 (31.3) | 34 (41.0) | |
| 0 | 5 (22.7) | 3 (16.7) | 6 (22.2) | 6 (37.5) | 20 (24.1) |
aTwo participants listed transgender male to female as their preferred gender identity. One participant’s gender was unknown.
bDistrust of medical system measured using the Health Care System Distrust Scale, which is scored from 10 (low distrust) to 50 (high distrust).
cEngagement-in-care is defined as having attended 2 or more HIV appointments separated by at least 90 days within the past year.
*Statistically significant differences between groups were observed for race, baseline viral suppression, and all app usage measures (p < .05).
Summary of typical PL usage by class
| Class 1: Maximizers | Class 2: Check-in Users | Class 3: Moderate All-Feature Users | Class 4: As-Needed Communicators | |
|---|---|---|---|---|
| Daily Check-in Response Rate | High | High | Moderate | Low |
| Community Board Posts | Ever Posted | Never Posted | Never Posted | Never Posted |
| Provider/Staff Messages Sent | High | Moderate | Moderate | Mixed |
Fig 1Prevalence of viral suppression (HIV viral load <200 copies/mL) at baseline, 6 months, and 12 months by user class. *Change in viral suppression shows a statistically significant increase among Moderate All-Feature Users and Overall group from baseline to six months. (p < .05).
Average rating for each PositiveLinks (PL) feature by class (N = 49)
| Maximizers | Check-in Users | Moderate All-Feature Users | As-Needed Communicators | |
|---|---|---|---|---|
| Appointment log | ||||
| Meana ( | 1.3 (0.5) |
|
|
|
| | 10 |
|
|
|
| Badges | ||||
| Mean ( | 0.9 (0.7) | 0.4 (0.7) | 0.8 (0.6) | 0.4 (0.5) |
| | 12 | 10 | 16 | 5 |
| Community board | ||||
| Mean ( |
|
| 0.8 (1.0) | 0.2 (1.2) |
| |
|
| 16 | 6 |
| Direct messaging | ||||
| Mean ( |
| 0.9 (1.2) |
|
|
| | 7 | 7 |
|
|
| General usability | ||||
| Mean ( | 1.2 (0.4) | 0.7 (0.8) | 1.0 (0.6) | 0.4 (0.9) |
| | 14 | 11 | 17 | 5 |
| Meds tracking | ||||
| Mean ( | 1.2 (0.8) | 0.9 (0.9) | 1.2 (0.8) | 0 (0.6) |
| | 12 | 12 | 15 | 6 |
| Mood/stress tracking | ||||
| Mean ( | 1.2 (0.8) | 0.7 (0.7) | 1.1 (0.8) | 0.2 (0.8) |
| | 13 | 12 | 17 | 6 |
| Resources | ||||
| Mean ( | 0.8 (0.8) | 0.7 (0.8) | 0.8 (0.6) | 0 (0.7) |
| | 13 | 10 | 16 | 5 |
| Weekly quizzes | ||||
| Mean ( | 1.0 (0.6) | 0.8 (0.8) | 0.9 (0.7) | 0.4 (0.9) |
| | 13 | 12 | 16 | 5 |
aRating options: −1 = negative; 0 = neutral; 1 = positive; 2 = strongly positive.
bHighest scoring features within each latent class are highlighted in bold.
Reasons for use and disuse by class (N = 49)
| Number of people (Number of times mentioned) | ||||
|---|---|---|---|---|
| Maximizers | Check-in Users | Moderate All-Feature Users | As-Needed Communicators | |
| Reasons for use | ||||
| Information/education | 5 (8) | 4 (4) | 7 (9) | 1 (1) |
| Educating self | 3 (4) | 3 (9) | 6 (9) | 0 |
| Educating others | 0 | 0 | 1 (5) | 0 |
| Insight | 8 (12) | 5 (6) | 9 (17) | 1 (1) |
| Memory/adherence | 7 (11) | 9 (18) | 10 (20) | 1 (1) |
| Positivity | 8 (13) | 5 (11) | 6 (6) | 0 |
| Social connection | 3 (3) | 4 (5) | 2 (2) | 1 (1) |
| With PL participants | 7 (12) | 4 (8) | 10 (13) | 2 (4) |
| With providers | 9 (17) | 6 (8) | 7 (16) | 2 (3) |
| With others | 0 | 0 | 1 (1) | 0 |
| Giving support | 5 (10) | 0 (0) | 3 (4) | 0 |
| Receiving support | 4 (8) | 2 (2) | 0 | 1 (2) |
| User friendliness/usability | 12 (15) | 7 (7) | 14 (20) | 2 (2) |
| Reasons for disuse/dislike | ||||
| Feature does not fit needs | 5 (6) | 1 (1) | 7 (12) | 2 (16) |
| Lack of awareness of feature | 4 (5) | 8 (12) | 5 (8) | 2 (3) |
| Lack of usability of app/ user-friendliness | 4 (5) | 3 (8) | 5 (7) | 0 |
| Privacy/anonymity | 0 | 0 | 1 (1) | 0 |
| Repetition/monotony | 3 (3) | 0 (0) | 3 (4) | 2 (6) |
| Social disconnection from PL community | 0 | 1 (1) | 0 | 2 (4) |
| Suggestions for improvement | 8 (13) | 6 (20) | 9 (12) | 2 (4) |